Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
CANO.WS was delisted on the 9th of November, 2023.
30 hedge funds and large institutions have $45.9M invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 12 closing their positions.
174% more capital invested
Capital invested by funds: $16.7M → $45.9M (+$29.1M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
9% less funds holding
Funds holding: 33 → 30 (-3)
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UFM
Ursa Fund Management
Danville,
California
|
+$4.13M |
| 2 |
Barclays
London,
United Kingdom
|
+$2.16M |
| 3 |
ZA
Zazove Associates
Incline Village,
Nevada
|
+$817K |
| 4 |
CCFM
Cohen & Co Financial Management
New York
|
+$442K |
| 5 |
DCM
Difesa Capital Management
New York
|
+$390K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$1.31M |
| 2 |
Walleye Capital
New York
|
-$855K |
| 3 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
-$670K |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$482K |
| 5 |
FBCM
Fort Baker Capital Management
Larkspur,
California
|
-$452K |
CANO.WS Hedge Fund Activity: Q3 2022 in Review
30 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q3 2022, worth a combined $45.9M — up 174% from $16.7M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of CANO.WS and 9 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 4 added.
The largest buyer was Ursa Fund Management, opening a new position worth an estimated $4.13M. The largest seller was LMR Partners, cutting an estimated $1.31M.
- 30 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q3 2022, down from 33 in Q2 2022.
- Funds reported $45.9M of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q3 2022, up 174% quarter-over-quarter.
- 9 funds opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q3 2022 and 12 closed out, a net change of -3 holders.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 buyer in Q3 2022 was Ursa Fund Management, an estimated $4.13M added.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q3 2022 was LMR Partners, an estimated $1.31M sold.
Based on aggregated 13F filings for Q3 2022.